Cite
Schwartzberg LS, Horinouchi H, Chan D, et al. Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance. NPJ Precis Oncol. 2020;4:15doi: 10.1038/s41698-020-0118-x.
Schwartzberg, L. S., Horinouchi, H., Chan, D., Chernilo, S., Tsai, M. L., Isla, D., Escriu, C., Bennett, J. P., Clark-Langone, K., Svedman, C., Tomasini, P. (2020). Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance. NPJ precision oncology, 415. https://doi.org/10.1038/s41698-020-0118-x
Schwartzberg, Lee S, et al. "Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance." NPJ precision oncology vol. 4 (2020): 15. doi: https://doi.org/10.1038/s41698-020-0118-x
Schwartzberg LS, Horinouchi H, Chan D, Chernilo S, Tsai ML, Isla D, Escriu C, Bennett JP, Clark-Langone K, Svedman C, Tomasini P. Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance. NPJ Precis Oncol. 2020 Jun 24;4:15. doi: 10.1038/s41698-020-0118-x. eCollection 2020. PMID: 32596507; PMCID: PMC7314769.
Copy
Download .nbib